These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18502905)

  • 1. The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology.
    Krajewski ML; Hsu LL; Gladwin MT
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H4-7. PubMed ID: 18502905
    [No Abstract]   [Full Text] [Related]  

  • 2. Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.
    Kaul DK; Zhang X; Dasgupta T; Fabry ME
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H39-47. PubMed ID: 18456737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.
    Kaul DK; Liu XD; Chang HY; Nagel RL; Fabry ME
    J Clin Invest; 2004 Oct; 114(8):1136-45. PubMed ID: 15489961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
    Akinsheye I; Klings ES
    J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell disease and nitric oxide: a paradigm shift?
    Mack AK; Kato GJ
    Int J Biochem Cell Biol; 2006; 38(8):1237-43. PubMed ID: 16517208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of Nitric Oxide Pathway by Intravascular Hemolysis Plays a Major Role in Mice Esophageal Hypercontractility: Reversion by Soluble Guanylyl Cyclase Stimulator.
    Henrique Silva F; Yotsumoto Fertrin K; Costa Alexandre E; Beraldi Calmasini F; Fernanda Franco-Penteado C; Ferreira Costa F
    J Pharmacol Exp Ther; 2018 Nov; 367(2):194-202. PubMed ID: 30108160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine metabolism and nitric oxide bioavailability in sickle cell disease.
    Jain S; Gladwin MT
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e247-8. PubMed ID: 20724948
    [No Abstract]   [Full Text] [Related]  

  • 8. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
    Wood KC; Granger DN
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse.
    Kaul DK; Liu XD; Fabry ME; Nagel RL
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1799-806. PubMed ID: 10843875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.
    Almeida CB; Souza LE; Leonardo FC; Costa FT; Werneck CC; Covas DT; Costa FF; Conran N
    Blood; 2015 Aug; 126(6):711-20. PubMed ID: 26019278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase and tissue injury.
    Traber DL
    Shock; 2000 Aug; 14(2):243-4. PubMed ID: 10947173
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytes.
    Nahavandi M; Tavakkoli F; Millis RM; Wyche MQ; Habib MJ; Tavakoli N
    Hematology; 2006 Aug; 11(4):291-4. PubMed ID: 17178670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic Hyperactivity, Increased Tyrosine Hydroxylase and Exaggerated Corpus Cavernosum Relaxations Associated with Oxidative Stress Plays a Major Role in the Penis Dysfunction in Townes Sickle Cell Mouse.
    Silva FH; Claudino MA; Calmasini FB; Alexandre EC; Franco-Penteado C; Burnett AL; Antunes E; Costa FF
    PLoS One; 2016; 11(12):e0166291. PubMed ID: 27935981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis.
    Deonikar P; Kavdia M
    J Appl Physiol (1985); 2012 Apr; 112(8):1383-92. PubMed ID: 22223452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced acute lung injury in murine models of sickle cell disease.
    Pritchard KA; Ou J; Ou Z; Shi Y; Franciosi JP; Signorino P; Kaul S; Ackland-Berglund C; Witte K; Holzhauer S; Mohandas N; Guice KS; Oldham KT; Hillery CA
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L705-14. PubMed ID: 12972407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
    Wood KC; Hsu LL; Gladwin MT
    Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide effect on the hemoglobin-oxygen affinity.
    Stepuro TL; Zinchuk VV
    J Physiol Pharmacol; 2006 Mar; 57(1):29-38. PubMed ID: 16601313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide pathology and therapeutics in sickle cell disease.
    Kim-Shapiro DB; Gladwin MT
    Clin Hemorheol Microcirc; 2018; 68(2-3):223-237. PubMed ID: 29614634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.
    Jison ML; Gladwin MT
    Am J Respir Crit Care Med; 2003 Jul; 168(1):3-4. PubMed ID: 12826592
    [No Abstract]   [Full Text] [Related]  

  • 20. An update on arginine in sickle cell disease.
    Benites BD; Olalla-Saad ST
    Expert Rev Hematol; 2019 Apr; 12(4):235-244. PubMed ID: 30855194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.